Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus

Psychoneuroendocrinology

Volumn 37, Issue 1, 2012, Pages 27-38

  Flandreau, Elizabeth I ^a   Ressler, Kerry J ^b,c   Owens, Michael J ^c   Nemeroff, Charles B ^d  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Amygdala; Anxiety; Corticotropin releasing factor (CRF); Depression; Hypothalamic pituitary adrenal (HPA) axis; Lentivirus

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; LENTIVIRUS VECTOR;

ADULT ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CENTRAL NUCLEUS (AMYGDALA); CEREBROSPINAL FLUID LEVEL; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; GENE OVEREXPRESSION; HIPPOCAMPUS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYGDALA; ANIMALS; ANXIETY DISORDERS; CORTICOTROPIN-RELEASING HORMONE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENETIC VECTORS; HIPPOCAMPUS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LENTIVIRUS; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL FUNCTION TESTS; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR;

EID: 83055188391     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.04.014     Document Type: Article

References (54)

1. DSM-IV-TR 2000, American Psychiatric Association, Washington, DC. Revised 4th ed.
2. Abelson J.L., Khan S., Liberzon I., Young E.A. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress. Anxiety 2007, 24(1):66-76.
3. Banki C.M., Karmacsi L., Bissette G., Nemeroff C.B. Cerebrospinal fluid neuropeptides in mood disorder and dementia. J. Affect. Disord. 1992, 25(1):39-45.
4. Buwalda B., de Boer S.F., Van Kalkeren A.A., Koolhaas J.M. Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat. Psychoneuroendocrinology 1997, 22(5):297-309.
5. Buwalda B., Van Kalkeren A.A., de Boer S.F., Koolhaas J.M. Behavioral and physiological consequences of repeated daily intracerebroventricular injection of corticotropin-releasing factor in the rat. Psychoneuroendocrinology 1998, 23(3):205-218.
6. Condren R.M., O'Neill A., Ryan M.C., Barrett P., Thakore J.H. HPA axis response to a psychological stressor in generalised social phobia. Psychoneuroendocrinology 2002, 27(6):693-703.
7. Contarino A., Dellu F., Koob G.F., Smith G.W., Lee K.F., Vale W.W., et al. Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice. Endocrinology 2000, 141(7):2698-2702.
8. Crane J.W., Buller K.M., Day T.A. Evidence that the bed nucleus of the stria terminalis contributes to the modulation of hypophysiotropic corticotropin-releasing factor cell responses to systemic interleukin-1beta. J. Comp. Neurol. 2003, 467(2):232-242.
9. Daniels W.M., Richter L., Stein D.J. The effects of repeated intra-amygdala CRF injections on rat behavior and HPA axis function after stress. Metab. Brain Dis. 2004, 19(1-2):15-23.
10. Drevets W.C. Neuroimaging abnormalities in the amygdala in mood disorders. Ann. N. Y. Acad. Sci. 2003, 985:420-444.
11. Eaton W.W., Shao H., Nestadt G., Lee H.B., Bienvenu O.J., Zandi P. Population-based study of first onset and chronicity in major depressive disorder. Arch. Gen. Psychiatry 2008, 65(5):513-520.
12. Fossey M.D., Lydiard R.B., Ballenger J.C., Laraia M.T., Bissette G., Nemeroff C.B. Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects. Biol. Psychiatry 1996, 39(8):703-707.
13. Gallagher J.P., Orozco-Cabal L.F., Liu J., Shinnick-Gallagher P. Synaptic physiology of central CRH system. Eur. J. Pharmacol. 2008, 583(2-3):215-225.
14. Garcia-Lecumberri C., Ambrosio E. Differential effect of low doses of intracerebroventricular corticotropin-releasing factor in forced swimming test. Pharmacol. Biochem. Behav. 2000, 67(3):519-525.
15. Gillespie C.F., Nemeroff C.B. Hypercortisolemia and depression. Psychosom. Med. 2005, 67(Suppl. 1):S26-S28.
16. Givalois L., Naert G., Rage F., Ixart G., Arancibia S., Tapia-Arancibia L. A single brain-derived neurotrophic factor injection modifies hypothalamo-pituitary-adrenocortical axis activity in adult male rats. Mol. Cell. Neurosci. 2004, 27(3):280-295.
17. Heinrichs S.C., Britton K.T., Koob G.F. Both conditioned taste preference and aversion induced by corticotropin-releasing factor. Pharmacol. Biochem. Behav. 1991, 40(4):717-721.
18. Heuser I., Yassouridis A., Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 1994, 28(4):341-356.
19. Holsboer F., Von Bardeleben U., Gerken A., Stalla G.K., Muller O.A. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N. Engl. J. Med. 1984, 311(17):1127.
20. Hugin-Flores M.E., Steimer T., Schulz P., Vallotton M.B., Aubert M.L. Chronic corticotropin-releasing hormone and vasopressin regulate corticosteroid receptors in rat hippocampus and anterior pituitary. Brain Res. 2003, 976(2):159-170.
21. Ising M., Kunzel H.E., Binder E.B., Nickel T., Modell S., Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(6):1085-1093.
22. Keen-Rhinehart E., Michopoulos V., Toufexis D.J., Martin E.I., Nair H., Ressler K.J., et al. Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes. Mol. Psychiatry 2009, 14(1):37-50.
23. Kompagne H., Bardos G., Szenasi G., Gacsalyi I., Harsing L.G., Levay G. Chronic mild stress generates clear depressive but ambiguous anxiety-like behaviour in rats. Behav. Brain Res. 2008, 193(2):311-314.
24. Kunugi H., Ida I., Owashi T., Kimura M., Inoue Y., Nakagawa S., et al. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a multicenter study. Neuropsychopharmacology 2006, 31(1):212-220.
25. Lowry C.A., Rose J.D., Moore F.L. Corticotropin-releasing factor enhances locomotion and medullary neuronal firing in an amphibian. Horm. Behav. 1996, 30(1):50-59.
26. Lu A., Steiner M.A., Whittle N., Vogl A.M., Walser S.M., Ableitner M., et al. Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior. Mol. Psychiatry 2008, 13(11):1028-1042.
27. Lucca G., Comim C.M., Valvassori S.S., Pereira J.G., Stertz L., Gavioli E.C., et al. Chronic mild stress paradigm reduces sweet food intake in rats without affecting brain derived neurotrophic factor protein levels. Curr. Neurovasc. Res. 2008, 5(4):207-213.
28. Martin E.I., Ressler K.J., Binder E., Nemeroff C.B. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr. Clin. N. Am. 2009, 32(3):549-575.
29. McIlwain K.L., Merriweather M.Y., Yuva-Paylor L.A., Paylor R. The use of behavioral test batteries: effects of training history. Physiol. Behav. 2001, 73(5):705-717.
30. Merali Z., Khan S., Michaud D.S., Shippy S.A., Anisman H. Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release. Eur. J. Neurosci. 2004, 20(1):229-239.
31. Murakami S., Imbe H., Morikawa Y., Kubo C., Senba E. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci. Res. 2005, 53(2):129-139.
32. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984, 226(4680):1342-1344.
33. Nishimori K., Young L.J., Guo Q., Wang Z., Insel T.R., Matzuk M.M. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(21):11699-11704.
34. Otte C., Hinkelmann K., Moritz S., Yassouridis A., Jahn H., Wiedemann K., et al. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. J. Psychiatr. Res. 2010, 44(6):339-346.
35. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, vol. 1. Elsevier Academic Press, Amsterdam/Boston. 5th ed.
36. Paxinos G., Watson C.R., Emson P.C. AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J. Neurosci. Methods 1980, 3(2):129-149.
37. Paylor R., Spencer C.M., Yuva-Paylor L.A., Pieke-Dahl S. The use of behavioral test batteries. II. Effect of test interval. Physiol. Behav. 2006, 87(1):95-102.
38. Pfleiderer B., Zinkirciran S., Arolt V., Heindel W., Deckert J., Domschke K. fMRI amygdala activation during a spontaneous panic attack in a patient with panic disorder. World. J. Biol. Psychiatry 2007, 8(4):269-272.
39. Rauch S.L., Shin L.M., Wright C.I. Neuroimaging studies of amygdala function in anxiety disorders. Ann. N. Y. Acad. Sci. 2003, 985:389-410.
40. Regev L., Neufeld-Cohen A., Tsoory M., Kuperman Y., Getselter D., Gil S., et al. Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation. Mol. Psychiatry 2010.
41. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117(6):2505-2511.
42. Reul J.M., Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2002, 2(1):23-33.
43. Risbrough V.B., Stein M.B. Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm. Behav. 2006, 50(4):550-561.
44. Schaaf M.J., de Jong J., de Kloet E.R., Vreugdenhil E. Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res. 1998, 813(1):112-120.
45. Skelton K.H., Nemeroff C.B., Knight D.L., Owens M.J. Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. J. Neurosci. 2000, 20(3):1240-1248.
46. Smith M.A., Makino S., Altemus M., Michelson D., Hong S.K., Kvetnansky R., et al. Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(19):8788-8792.
47. Stenzel-Poore M.P., Heinrichs S.C., Rivest S., Koob G.F., Vale W.W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 1994, 14(5 Pt. 1):2579-2584.
48. Sterlemann V., Ganea K., Liebl C., Harbich D., Alam S., Holsboer F., et al. Long-term behavioral and neuroendocrine alterations following chronic social stress in mice: implications for stress-related disorders. Horm. Behav. 2008, 53(2):386-394.
49. Sutton R.E., Koob G.F., Le Moal M., Rivier J., Vale W. Corticotropin releasing factor produces behavioural activation in rats. Nature 1982, 297(5864):331-333.
50. Tezval H., Jahn O., Todorovic C., Sasse A., Eckart K., Spiess J. Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(25):9468-9473.
51. Torashima T., Yamada N., Itoh M., Yamamoto A., Hirai H. Exposure of lentiviral vectors to subneutral pH shifts the tropism from Purkinje cell to Bergmann glia. Eur. J. Neurosci. 2006, 24(2):371-380.
52. Veldhuis H.D., De Wied D. Differential behavioral actions of corticotropin-releasing factor (CRF). Pharmacol. Biochem. Behav. 1984, 21(5):707-713.
53. Welberg L.A., Kinkead B., Thrivikraman K., Huerkamp M.J., Nemeroff C.B., Plotsky P.M. Ketamine-xylazine-acepromazine anesthesia and postoperative recovery in rats. J. Am. Assoc. Lab. Anim. Sci. 2006, 45(2):13-20.
54. Weninger S.C., Dunn A.J., Muglia L.J., Dikkes P., Miczek K.A., Swiergiel A.H., et al. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(14):8283-8288.